| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Neurology, University of Oregon Health Sciences Center, Portland, OR.
A retrospective review of the hospital course of 44 patients with embolic cerebral infarction was carried out. Eleven patients (25%) suffered recurrent embolic infarction. Three of the recurrences were fatal. Two patients suffered a recurrence within 48 hours of the initial event, and an additional patient suffered a recurrence 6 days after the initial event. Sixteen embolic infarctions were managed with therapeutic anticoagulation within 48 hours without adverse effect. The clinical and experimental data concerning early anticoagulation after embolic infarction were reviewed. It appears that the risk of early anticoagulation is less than the risk of recurrent embolic infarction.
Address correspondence and reprint requests to Dr. Koller, Metropolitan Medical Office Building, 825 South Eighth Street, Noran Neurological Clinic, Suite 600, Minneapolis, MN 55404.
Accepted for publication August 4, 1981.
This article has been cited by other articles:
|
|
 |
|
  M. Moonis and M. Fisher Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic Stroke Stroke, July 1, 2002; 33(7): 1927 - 1933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J DEL ZOPPO, R. VON KUMMER, and G. F HAMANN Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 1 - 9. [Full Text]
|
|
|
|
|
|
V. L. Babikian, C. A. C. Wijman, C. Hyde, N. L. Cantelmo, M. R. Winter, E. Baker, and V. Pochay Cerebral Microembolism and Early Recurrent Cerebral or Retinal Ischemic Events Stroke, July 1, 1997; 28(7): 1314 - 1318. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. G. Naglie and A. S. Detsky Treatment of Chronic Nonvalvular Atrial Fibrillation in the Elderly: A Decision Analysis Med Decis Making, December 1, 1992; 12(4): 239 - 249. [Abstract] [PDF]
|
|
|
|
 |
|
 P. D. Lyden, J. A. Zivin, M. Soll, M. Sitzer, J. F. Rothrock, and J. Alksne Intracerebral Hemorrhage After Experimental Embolic Infarction: Anticoagulation Arch Neurol, August 1, 1987; 44(8): 848 - 850. [Abstract] [PDF]
|
|
|
|
|
|
M. Ramirez-Lassepas, R. J. Cipolle, R. J. Bjork, J. Kowitz, B. D. Snyder, J. C. Weber, and S. D. Stein Can Embolic Stroke Be Diagnosed on the Basis of Neurologic Clinical Criteria? Arch Neurol, January 1, 1987; 44(1): 87 - 89. [Abstract] [PDF]
|
|
|
|
|
|
M. Ramirez-Lassepas, M. R. Quinones, and H. H. Nino Treatment of Acute Ischemic Stroke: Open Trial With Continuous Intravenous Heparinization Arch Neurol, April 1, 1986; 43(4): 386 - 390. [Abstract] [PDF]
|
|
|
|
|
|
I. Starkey and C. Warlow The Secondary Prevention of Stroke in Patients With Atrial Fibrillation Arch Neurol, January 1, 1986; 43(1): 66 - 68. [Abstract] [PDF]
|
|
|
|
|
|
Cerebral Embolism Task Force Cardiogenic Brain Embolism Arch Neurol, January 1, 1986; 43(1): 71 - 84. [Abstract] [PDF]
|
|
|
|
|
|
R. G. Hart Early Recurrent Embolism Rheumatic Heart Disease Arch Neurol, November 1, 1985; 42(11): 1033 - 1033. [Abstract] [PDF]
|
|
|
|
|
|
J. Bogousslavsky Anticoagulation and Bleeding Into Embolic Infarcts Arch Neurol, November 1, 1985; 42(11): 1033 - 1034. [Abstract] [PDF]
|
|
|
|
|
|
J. I. Sage Stroke: The Use and Overuse of Heparin in Therapeutic Trials Arch Neurol, April 1, 1985; 42(4): 315 - 317. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
